NewsRx

Search our medical news database

Uterine Cancer

Estrogen for Survivors of Uterine Cancer? A New Study Will Resolve Debate

Published in Cancer Weekly, May 26th, 1997

The first large, national study of estrogen replacement therapy (ERT) for women who have had cancer of the uterus will start enrolling patients this summer, researchers announced at the annual meeting of The American College of Obstetricians and Gynecologists (ACOG) in Las Vegas.

The study is designed to resolve the current controversy over the safety of estrogen replacement for survivors of uterine, or endometrial, cancer.

The ERT Study is being sponsored by the National Cancer Institute (NCI) and organized by the Gynecologic Oncology Group (GOG), a program of ACOG. GOG is one of 11 cooperative trial groups -- networks of medical centers that...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook